Pfizer full product portfolio to 45 lower income countries

 

 

 

 

 

 

 

 

 

 

• _Pfizer said it expanded its commitment to 'An Accord for a Healthier World' to offer the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis for 45 lower-income countries.
•  _Launched in May 2022, the Accord, an initiative focused on reducing health inequities between countries, initially included a commitment from Pfizer for patented drugs and vaccines available in the U.S. or EU on a not-for-profit basis to 45 lower-income countries. 
• _Pfizer will now expand its total offering from 23 products to ~500 products. The medicines include chemotherapies and oral cancer treatments, according to the company. 
• _The commitment builds on already delivered drugs and medical training and supply chain support to Rwanda and advanced discussions with 16 other Accord country governments for supply and health system support, the company added. 
• _Rwanda has already received delivery of nine Pfizer drugs and vaccines for certain cancers, infectious and inflammatory diseases, according to the company. Ver